GILD vs. LLY
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or LLY.
Correlation
The correlation between GILD and LLY is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GILD vs. LLY - Performance Comparison
Loading data...
Key characteristics
GILD:
2.11
LLY:
-0.03
GILD:
3.01
LLY:
0.27
GILD:
1.38
LLY:
1.04
GILD:
1.92
LLY:
-0.00
GILD:
10.43
LLY:
-0.00
GILD:
5.49%
LLY:
12.85%
GILD:
27.11%
LLY:
38.42%
GILD:
-70.82%
LLY:
-68.27%
GILD:
-12.09%
LLY:
-20.68%
Fundamentals
GILD:
$127.61B
LLY:
$679.94B
GILD:
$4.86
LLY:
$12.72
GILD:
21.09
LLY:
59.54
GILD:
0.21
LLY:
1.12
GILD:
4.44
LLY:
13.88
GILD:
6.52
LLY:
41.76
GILD:
$28.73B
LLY:
$49.00B
GILD:
$23.07B
LLY:
$40.03B
GILD:
$9.89B
LLY:
$16.67B
Returns By Period
In the year-to-date period, GILD achieves a 11.75% return, which is significantly higher than LLY's -1.52% return. Over the past 10 years, GILD has underperformed LLY with an annualized return of 2.76%, while LLY has yielded a comparatively higher 28.68% annualized return.
GILD
11.75%
-1.95%
17.75%
57.04%
10.94%
2.76%
LLY
-1.52%
-9.65%
1.88%
-0.96%
38.57%
28.68%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. LLY — Risk-Adjusted Performance Rank
GILD
LLY
GILD vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GILD vs. LLY - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 3.02%, more than LLY's 0.74% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 3.02% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% |
LLY Eli Lilly and Company | 0.74% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
GILD vs. LLY - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, roughly equal to the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for GILD and LLY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GILD vs. LLY - Volatility Comparison
The current volatility for Gilead Sciences, Inc. (GILD) is 11.99%, while Eli Lilly and Company (LLY) has a volatility of 22.29%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GILD vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GILD vs. LLY - Profitability Comparison
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a gross profit of 5.71B and revenue of 6.67B. Therefore, the gross margin over that period was 85.6%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported an operating income of 3.15B and revenue of 6.67B, resulting in an operating margin of 47.2%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.